Stomatitis Clinical Trials

5 recruiting

Stomatitis Trials at a Glance

8 actively recruiting trials for stomatitis are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 2 with 3 trials, with the heaviest enrollment activity in Washington D.C., Albemarle, and Albuquerque. Lead sponsors running stomatitis studies include Batman University, Instituto Nacional de Cancer, Brazil, and Baptist Health South Florida.

Browse stomatitis trials by phase

Treatments under study

About Stomatitis Clinical Trials

Looking for clinical trials for Stomatitis? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Stomatitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Stomatitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 2

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Head and Neck Squamous Cell CarcinomaStage III Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+38 more
NRG Oncology98 enrolled149 locationsNCT06532279
Recruiting
Not Applicable

MucoLock™ for Treatment of Stomatitis

PainStomatitisBurning Mouth
Baptist Health South Florida25 enrolled1 locationNCT07506018
Recruiting
Phase 2

Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients

Oral MucositisHematopoietic Stem Cell TransplantationStomatitis+1 more
The First Affiliated Hospital of Soochow University22 enrolled1 locationNCT07400328
Recruiting

Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Other Tonsil Disorders

Obstructive Sleep ApneaTonsillitisPeriodic Fever, Aphthous Stomatitis, Pharyngitis, And Cervical Adenitis (Pfapa)+1 more
National Institute of Allergy and Infectious Diseases (NIAID)1,500 enrolled3 locationsNCT05656365
Recruiting
Phase 3

Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast Versus Placebo in Severe Forms of Recurrent Aphthous Stomatitis

Recurrent Aphtous Stomatitis
University Hospital, Rouen134 enrolled21 locationsNCT04227314
Recruiting
Phase 2

Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy

MucositisStomatitis
Niels Fristrup100 enrolled2 locationsNCT03581773
Recruiting
Not Applicable

Effect of St. John's Wort in the Treatment of Recurrent Aphthous Stomatitis

Stomatitis, Aphthous
Batman University75 enrolled1 locationNCT06839313
Recruiting
Phase 3

Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogenetic HSCT

Hematopoietic Stem Cell TransplantationStomatitisLow-Level Light Therapy
Instituto Nacional de Cancer, Brazil84 enrolled2 locationsNCT06071637